Chris Lowe

Chris has a PhD in Medical Genetics from the University of Cambridge where he engaged in research on Type 1 diabetes in the Diabetes and Inflammation Laboratory headed by Professor John Todd.

Afterwards, he performed Post-Doctoral research in the laboratory of Professor Sir Steve O’Rahilly at the University of Cambridge Metabolic Research Laboratory.

Chris’s work at these two laboratories has resulted in numerous publications.

In 2011, Chris Joined Horizon to work within and then develop and lead the Cell Line Validation team before merging and taking responsibility for the Cell Line Production group.

Chris Lowe is the Head of Research Operations at Horizon Discovery, based in Europe. With a background in Biotechnology, Chris Lowe has a rich history of leadership and innovation.Chris Lowe studied Ph.D Medical Genetics at University of Cambridge. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.